CLINICAL_TRIALS
trial_result
· 2015-03-12
Clinical Trial Update: Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
Summary
A Phase 3 trial update reports on the efficacy and safety of pirfenidone in idiopathic pulmonary fibrosis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2015-03-12